Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/29/2010EP1828249B1 Biomarkers for pre-selection of patients for anti-igf1r therapy
12/29/2010EP1810681B1 Intestinal polyp inhibitor
12/29/2010EP1809620B1 Novel tetrazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
12/29/2010EP1805183B1 Novel diazabicyclic aryl derivatives and their medical use
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1776360B1 3-(heteroaryl-oxy)-2-alkyl-1-aza-bicycloalkyl derivatives as alpha.7-nachr ligands for the treatment of cns diseases.
12/29/2010EP1758578B1 Novel indazole carboxamides and their use
12/29/2010EP1732575B1 Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
12/29/2010EP1725244B1 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
12/29/2010EP1717237B1 Anthranilamides, process for the production thereof, and pest controllers containing the same
12/29/2010EP1716160B1 Novel inhibitors of chymase
12/29/2010EP1713810B1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
12/29/2010EP1689415B1 Improving iron uptake
12/29/2010EP1651656B1 Process for controlling crystal structure of risedronate
12/29/2010EP1621202B1 Freeze-dried preparation containing methylcobalamin and process for producing the same
12/29/2010EP1576959B1 Softgel of nlkj (neutral lipids obtained from kernels of job's tears) for treating prostate diseases
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010EP1545429B1 Compositions containing citric acid for the treatment of nail fungal infections
12/29/2010EP1542658B1 Pharmaceutical compositions comprising an opioid analgesic
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1494705B1 A composition and method for killing of tumours
12/29/2010EP1487802B1 2,3-Diaryl-pyrazolidine derivatives as neurotensin degrading enzyme inhibitors
12/29/2010EP1441727B1 Depot formulations of iloperidone and a star polymer
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1404312B1 Carbamate compounds for use in the treatment of pain
12/29/2010EP1387673B1 Abuse-resistant controlled-release opioid dosage form
12/29/2010EP1372603B1 Topical application for treating toenail fungus
12/29/2010EP1370530B1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/29/2010EP1362119B1 Glucosamine and method of making glucosamine from microbial biomass
12/29/2010EP1345611B1 An antibiotic/analgesic formulation and a method of making this formulation
12/29/2010EP1315424B1 Oil/fat composition
12/29/2010EP1292573B1 Substituted thioacetamides
12/29/2010EP1286657B1 Nasal ointment based on white petroleum jelly
12/29/2010EP1183022B1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response
12/29/2010EP1107722B1 A method for the treatment of staphylococcal infection
12/29/2010EP1077678B1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
12/29/2010EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/29/2010CN1989439B Methods and compositions for the treatment of uveitis
12/29/2010CN1980579B Prebiotic preparation
12/29/2010CN1976723B Use of preparing medicine for treating or preventing infectious diseases
12/29/2010CN1969984B Externally applied medicament for treating acne and allergy
12/29/2010CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
12/29/2010CN1956707B Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-D-glutamic acid (LK-423)
12/29/2010CN1946392B Use of acethyldiacylglycerole derivatives in preparing autoimmune agents and health food
12/29/2010CN1929861B CTGF as target for the therapy of diabetic nephropathy
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN1902196B Thiazole derivative
12/29/2010CN1899643B Pessary or intrauterine medicine release device containing antiestrogenic and anti-pregnant hormone composite preparation and its use
12/29/2010CN1895371B Inebriant for treating scald and burn
12/29/2010CN1867328B Use of lipid glyceride in preparing medicine for treatment of neurodegenerative conditions
12/29/2010CN1863558B Polyarginine-modified liposome capable of transferring into nucleus
12/29/2010CN1824063B Medicine and food dual purpose Chinese and western medicine combined product for preventing and trecting pseudomyopia
12/29/2010CN1799550B Highly efficient formulation of hepsera and preparation method thereof
12/29/2010CN1780829B Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof
12/29/2010CN1739519B Itraconazole emulsion for injection and its preparation
12/29/2010CN1682737B Compound dimethylbiguanide/glipizide control release tablet and preparing method
12/29/2010CN101932939A Marker for determination of sensitivity to anti-cancer agent
12/29/2010CN101932719A Branched -glucan, -glucosyltransferase producing the same, method for producing the same and use thereof
12/29/2010CN101932590A 2',4'-substituted nucleosides as antiviral agents
12/29/2010CN101932587A Thiazolopyrimidine p13k inhibitor compounds and methods of use
12/29/2010CN101932586A Inhibitors of protein tyrosine kinase activity
12/29/2010CN101932585A Substituted spirocyclic piperidine derivatives as histamine-3 (h3) receptor ligands
12/29/2010CN101932584A Pyrrolopyrimidin derivative for use as pi3k inhibitor, and use thereof
12/29/2010CN101932583A Pyrazolo [1,5-a] pyrimidines useful as jak2 inhibitors
12/29/2010CN101932582A Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
12/29/2010CN101932580A Imidazopyridine kinase inhibitors
12/29/2010CN101932579A New imidazolo-heteroaryl derivatives with antibacterial properties
12/29/2010CN101932578A Gamma secretase modulators
12/29/2010CN101932577A Heteroaryl-substituted piperidines
12/29/2010CN101932576A Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
12/29/2010CN101932575A Piperidine derivative
12/29/2010CN101932574A 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
12/29/2010CN101932573A Novel pyridinones and pyridazinones
12/29/2010CN101932572A Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide
12/29/2010CN101932571A Compounds having crth2 antagonist activity
12/29/2010CN101932570A Trpv1 antagonists and uses thereof
12/29/2010CN101932568A Thiazole derivative and use thereof as vap-1 inhibitor
12/29/2010CN101932565A Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
12/29/2010CN101932564A Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
12/29/2010CN101932563A Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use
12/29/2010CN101932562A Carbamoyl compounds as dgat1 inhibitors 190
12/29/2010CN101932561A Crystalline form of an antimalarial compound
12/29/2010CN101932557A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
12/29/2010CN101932552A 2-amino-2-phenylalkanol derivatives, preparation thereof and pharmaceutical compositions containing same
12/29/2010CN101932551A Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use
12/29/2010CN101932338A Method for determination of sensitivity to anti-cancer agent
12/29/2010CN101932335A Medicament for the treatment of cancer of the pancreas
12/29/2010CN101932329A Adhesive patch
12/29/2010CN101932328A Antiviral agents, antiviral fibers and antiviral fiber structures
12/29/2010CN101932327A Dosing regimen associated with long acting injectable paliperidone esters
12/29/2010CN101932325A Ido inhibitors
12/29/2010CN101932324A Prolyl hydroxylase inhibitors
12/29/2010CN101932323A Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis
12/29/2010CN101932322A Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid
12/29/2010CN101932321A Combination therapy comprising sglt inhibitors and dpp4 inhibitors
12/29/2010CN101932320A Membrane fusion inhibitor
12/29/2010CN101932319A Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
12/29/2010CN101932318A Composition for stimulating natural killer cell activity
1 ... 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 ... 7860